A carregar...
Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy
Diabetic retinopathy (DR) is a leading cause of vision loss with retinal vascular leakage and/or neovascularization. Current antiangiogenic therapy against vascular endothelial growth factor (VEGF) has limited efficacy. In this study, we applied a new technology of comparative ligandomics to diabeti...
Na minha lista:
| Publicado no: | J Exp Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Rockefeller University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5379984/ https://ncbi.nlm.nih.gov/pubmed/28330905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20161802 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|